Insider · CIK 0001359446

Ford Alfred J Jr

Reports to the SEC for 3 companies · KIRKLAND, WA

sec.gov

Transactions

Companies

Filings

CIK

0001359446

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-04	KMTSKESTRA MEDICAL TECHNOLOGIES, LTD.S Sale	Chief Commercial Officer	SSale	−6,275 sh	$24.09	−$151K	99,564
2026-08-03	KMTSKESTRA MEDICAL TECHNOLOGIES, LTD.S Sale	Chief Commercial Officer	SSale	−13K sh	$23.90	−$311K	105,839
2026-07-31	KMTSKESTRA MEDICAL TECHNOLOGIES, LTD.S Sale	Chief Commercial Officer	SSale	−8,681 sh	$22.61	−$196K	118,854
2026-07-30	KMTSKESTRA MEDICAL TECHNOLOGIES, LTD.S Sale	Chief Commercial Officer	SSale	−5,936 sh	$22.76	−$135K	127,535
2026-07-15	KMTSKESTRA MEDICAL TECHNOLOGIES, LTD.A Award	Chief Commercial Officer	AAward	+58.8K sh	—	—	133,471
2026-06-03	KMTSKESTRA MEDICAL TECHNOLOGIES, LTD.A Award	Chief Commercial Officer	AAward	+25.2K sh	—	—	74,639
2025-07-17	KMTSKESTRA MEDICAL TECHNOLOGIES, LTD.A Award	Chief Commercial Officer	AAward	+29.4K sh	—	—	29,412
2025-03-07	KMTSKESTRA MEDICAL TECHNOLOGIES, LTD.P Purchase	Chief Commercial Officer	PPurchase	+20K sh	$17.00	+$340K	49,412
2024-11-15	Axonics, Inc.Performance-Based Restricted Stock UnitsD Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−11.3K sh	—	—	0
2024-11-15	Axonics, Inc.D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−43.5K sh	$71.00	−$3.08M	0
2024-11-15	Axonics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−4,655 sh	$45.18	−$210K	0
2024-01-31	Axonics, Inc.Performance-Based Restricted Stock UnitsM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−15K sh	—	—	0
2024-01-31	Axonics, Inc.Performance-Based Restricted Stock UnitsM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−10.5K sh	—	—	0
2024-01-31	Axonics, Inc.S Sale	Chief Commercial Officer	SSale	−16.6K sh	$67.74	−$1.13M	43,450
2024-01-31	Axonics, Inc.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+25.5K sh	—	—	60,065
2023-08-15	Axonics, Inc.S Sale	Chief Commercial Officer	SSale	−14.8K sh	$62.34	−$921K	34,565
2023-07-28	Axonics, Inc.S Sale	Chief Commercial Officer	SSale	−1,500 sh	$62.01	−$93K	49,334
2023-02-01	Axonics, Inc.S Sale	Chief Commercial Officer	SSale	−3,164 sh	$61.02	−$193K	50,834
2023-02-01	Axonics, Inc.S Sale	Chief Commercial Officer	SSale	−541 sh	$60.43	−$32.7K	53,998
2023-01-31	Axonics, Inc.Performance-Based Restricted Stock UnitsM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−5,250 sh	—	—	0
2023-01-31	Axonics, Inc.A Award	Chief Commercial Officer	AAward	+7,500 sh	—	—	44,273
2023-01-31	Axonics, Inc.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+16.5K sh	—	—	60,773
2023-01-31	Axonics, Inc.S Sale	Chief Commercial Officer	SSale	−4,235 sh	$61.17	−$259K	56,538
2023-01-31	Axonics, Inc.S Sale	Chief Commercial Officer	SSale	−1,999 sh	$61.12	−$122K	54,539
2023-01-31	Axonics, Inc.Performance-Based Restricted Stock UnitsA Award	Chief Commercial Officer	AAward	+15K sh	—	—	15,000
2023-01-31	Axonics, Inc.Performance-Based Restricted Stock UnitsA Award	Chief Commercial Officer	AAward	+7,500 sh	—	—	7,500
2023-01-31	Axonics, Inc.Performance-Based Restricted Stock UnitsM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−11.3K sh	—	—	0
2023-01-13	Axonics, Inc.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+1,899 sh	$1.63	+$3,095.37	47,181
2023-01-13	Axonics, Inc.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+9,310 sh	$25.82	+$240K	56,491
2023-01-13	Axonics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−8,509 sh	—	—	0
2023-01-13	Axonics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−1,899 sh	—	—	0
2023-01-13	Axonics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−16.3K sh	—	—	0
2023-01-13	Axonics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−9,310 sh	—	—	4,655
2023-01-13	Axonics, Inc.S Sale	Chief Commercial Officer	SSale	−3,615 sh	$67.18	−$243K	36,773
2023-01-13	Axonics, Inc.S Sale	Chief Commercial Officer	SSale	−17.1K sh	$66.69	−$1.14M	40,388
2023-01-13	Axonics, Inc.S Sale	Chief Commercial Officer	SSale	−15.3K sh	$65.90	−$1.01M	57,496
2023-01-13	Axonics, Inc.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+16.3K sh	$14.19	+$231K	72,788
2023-01-13	Axonics, Inc.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+8,509 sh	$1.42	+$12.1K	45,282
2022-02-03	Axonics, Inc.Performance-Based Restricted Stock UnitsM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−14.1K sh	—	—	0
2022-02-03	Axonics, Inc.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+24.1K sh	—	—	46,040
2022-02-03	Axonics, Inc.S Sale	Chief Commercial Officer	SSale	−8,797 sh	$48.21	−$424K	37,243
2022-02-03	Axonics, Inc.S Sale	Chief Commercial Officer	SSale	−470 sh	$49.03	−$23K	36,773
2022-02-03	Axonics, Inc.Performance-Based Restricted Stock UnitsM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−10K sh	—	—	0
2022-01-31	Axonics, Inc.Performance-Based Restricted Stock UnitsA Award	Chief Commercial Officer	AAward	+5,250 sh	—	—	5,250
2022-01-31	Axonics, Inc.A Award	Chief Commercial Officer	AAward	+16.3K sh	—	—	21,910
2022-01-31	Axonics, Inc.Performance-Based Restricted Stock UnitsA Award	Chief Commercial Officer	AAward	+5,250 sh	—	—	5,250
2021-04-19	Axonics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−6,347 sh	—	—	13,965
2021-04-19	Axonics, Inc.S Sale	Chief Commercial Officer	SSale	−12.5K sh	$59.33	−$742K	5,625
2021-04-19	Axonics, Inc.S Sale	Chief Commercial Officer	SSale	−41.8K sh	$58.33	−$2.44M	18,127
2021-04-19	Axonics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−14.9K sh	—	—	8,509

Recent filings

Accepted (ET)
Aug 64
Ford Alfred J Jr0001193125-26-338668
SEC(opens sec.gov)
Aug 34
Ford Alfred J Jr0001193125-26-331065
SEC(opens sec.gov)
Jul 174
Ford Alfred J Jr0001193125-26-308046
SEC(opens sec.gov)
Jun 44
Ford Alfred J Jr0001193125-26-257913
SEC(opens sec.gov)
Sep 154/A
Ford Alfred J Jr0001193125-25-203649
SEC(opens sec.gov)
Jul 214
Ford Alfred J Jr0000950170-25-097312
SEC(opens sec.gov)
Nov 154
Ford Alfred J Jr0001562180-24-007704
SEC(opens sec.gov)
Feb 24
Ford Alfred J Jr0001562180-24-001011
SEC(opens sec.gov)
Aug 174
Ford Alfred J Jr0001562180-23-006422
SEC(opens sec.gov)
Aug 14
Ford Alfred J Jr0001562180-23-006100
SEC(opens sec.gov)
Feb 24
Ford Alfred J Jr0001562180-23-000875
SEC(opens sec.gov)

Companies

Address

3933 LAKE WASHINGTON BLVD NE, SUITE 200

KIRKLAND, WA, 98033